Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults with Asthma on Medium-to-High Dose Inhaled Corticosteroids

Trial Identifier: D2912C00003
Sponsor: AstraZeneca
NCTID:: NCT04643158
Start Date: March 2021
Primary Completion Date: February 2024
Study Completion Date: February 2024
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Herston, AU, 4006
AU Kent Town, AU, 5067
AU Melbourne, AU, IC 3004
AU Nedlands, AU, 6009
CA, ON Windsor, ON, CA, N8X 1T3
DE Berlin, DE, 10969
DE Berlin, DE, 10717
DE Berlin, DE, 10119
DE Berlin, DE, 14050
DE Berlin, DE, 10625
DE Bonn, DE, 53119
DE Frankfurt, DE, 60596
DE Hamburg, DE, 20354
DE Hannover, DE, D-30173
DE Lübeck, DE, 23552
DE Mainz, DE, 55128
DE Neu-Isenburg, DE, 63263
DE Reinfeld, DE, 23858
ES Barcelona, ES, 08916
ES Barcelona, ES, 08036
ES Barcelona, ES, 08208
ES Bilbao (Vizcaya), ES, 48013
ES Cádiz, ES, 11009
ES Santander, ES, 39008
ES Santiago de Compostela, ES, 15706
ES Torrelavega, ES, 39300
ES Villarreal (Castellón), ES, 12540
GB Barnet, GB, EN5 3DJ
GB High Wycombe, GB, HP11 2QW
GB Liverpool, GB, L7 8XP
GB London, GB, SE1 9RT
GB London, GB, W1G 8HU
HU Budapest, HU, 1204
HU Kaposvár, HU, 7400
HU Nyíregyháza, HU, 4400
HU Pécs, HU, 7635
HU Szombathely, HU, 9700
KR Busan, KR, 48108
KR Cheongiu, KR, 28644
KR Chuncheon, KR, 24289
KR Gyeonggi-do, KR, 13620
KR Incheon, KR, 21431
KR Namdong-gu, KR, 21565
KR Seoul, KR, 05505
KR Seoul, KR, 03312
KR Seoul, KR, 136-705
KR Seoul, KR, 08308
KR Seoul, KR, 06591
KR Suwon-si, KR, 16499
PL Białystok, PL, 15-044
PL Krakow, PL, 30-033
PL Krakow, PL, 31-501
PL Kraków, PL, 31-559
PL Lodz, PL, 90-302
PL Łódź, PL, 90-153
PL Lubin, PL, 59-300
PL Sopot, PL, 81-741
PL Wroclaw, PL, 53-201
PL Wrocław, PL, 53-301
TW Kaohsiung, TW, 807
UA Kiev, UA, 02000